Direct targeting and induction of immunological attacks on cancer cells are two widely used approaches for the treatment of cancer. But Professor Hiromi Kumon and colleagues at Okayama University have developed a third and potentially more effective approach based on Reduced Expression in Immortalized Cells -a tumor suppressor gene discovered at Okayama University.
